Polymed Scores a Generic Win Over B Braun again

For Poly Medicure Limited it was another shot in the arm when on
December 4, 2009 the double bench of the Hon'ble Delhi High Court
passed order agreeing with observations of the order dated April 15,
2009 of the Hon'ble single judge and rejecting the interim application
filed by B Braun Melsungen AG with its appeal, said a company press
release of Polymed. Consequently, Poly Medicure Ltd. has no
restriction to manufacture and sell its safety IV catheters.

The release further states that double bench of the Delhi High Court
in its order dated December 4, 2009 found lapses by B Braun Melsungen
AG in following the procedure for amendment of the claims as "post-
grant amendment was sought in the garb of pre-grant amendment for the
sole purpose of avoiding publication of the same." The bench while
rejecting the interim application for grant of interim stay agreed
with the findings of the single judge that "prima facie, there is a
serious challenge to the validity of the patent", also agreed with the
following observations of the learned single judge that "the question
of validity of the plaintiffs' Patent No.210062 is not free from doubt
at this prima facie stage. There are more reasons than one for
entertaining such doubts."

"India being the main production centre for Poly Medicure Ltd. for its
safety IV catheters, Poly Medicure Ltd is not in any way prohibited
from manufacturing and marketing in India or any part of the world its
safety IV catheters, except presently in Germany where the Poly
Medicure Ltd. has already filed an appeal in the Court in Dusseldorf
and is very hopeful to get a favourable decision soon," the release
stated.

-- 
You received this message because you are subscribed to the Google Groups 
""GLOBAL SPECULATORS"" group.
To post to this group, send email to [email protected].
To unsubscribe from this group, send email to 
[email protected].
For more options, visit this group at 
http://groups.google.com/group/globalspeculators?hl=en.

Reply via email to